FDAnews Device Daily Bulletin

UROPLASTY'S NEXT-GENERATION DEVICE TO TREAT OVERACTIVE BLADDER AWARDED CE MARKING

June 23, 2006
A A

Uroplasty, Inc. announced their second major approval for the Company's next-generation Urgent PC Neuromodulation System. AMTAC Certification Services, Uroplasty's Notified Body, granted European CE marking and approved the Company's request to sell this new model of the Urgent PC in Europe for the treatment of overactive bladder symptoms and for the treatment of fecal incontinence. Regulatory clearance from the U.S. FDA is currently pending.
Pipeline Review